VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on ...

The 30,000-square-foot New Jersey Innovation Hub at HELIX offers laboratory space and other resources to early-stage ...

Biotech Open Platform has inaugurated a new biotechnology platform in Clermont-Ferrand, France, as it seeks to bridge the gap between laboratory development and industrial-scale production while ...

Clinical trials are a key driver of biotech stocks. Every new therapy must pass through a series of testing, Phase 1, Phase 2 ...

Chinese biotechs can run trials 50–70% faster – our report shows where that speed is paying off, and where the road narrows.

Agriculture today faces major challenges: climate change, tightening regulatory requirements, the progressive withdrawal of ...

The European Food Safety Authority (EFSA) has published a roadmap for European food regulation over the next decade, ...

DALLAS TX. - Green Leaf Innovations, Inc. (OTC: GRLF) is pursuing an agricultural expansion that could connect its premium cigar business with a new opportunity: commercializing organic fertilizers ...

Six advanced biotech firms from Korea's Daedeok research zone pitched their technologies at Otsuka Pharmaceutical's Tokyo ...

September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals.

Europe’s inaugural C-suite survey, shared with European Biotechnology, shows a sector expecting better funding conditions while struggling with investor caution. Among 69 executives at ...